This is illustrated by the study of Zhu et al [100] of 241 cases of leukemia (134x acute myeloid leukemia (AML) and 107x acute lymphcytic leukemia (ALL)) in which only 8 of the 19 somatic SETD2 mutations identified in 15 patients were truncating. This evidence concerns the gene SETD2 and leukemia.